Analyst Price Targets — BRKR
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| June 29, 2026 10:59 am | Subbu Nambi | Guggenheim | $70.00 | $60.91 | TheFly | Bruker price target raised to $70 from $50 at Guggenheim |
| June 24, 2026 8:50 am | — | UBS | $60.00 | $55.11 | TheFly | Bruker price target raised to $60 from $53 at Barclays |
| May 8, 2026 11:19 am | Daniel Arias | Stifel Nicolaus | $45.00 | $43.73 | TheFly | Bruker price target raised to $45 from $40 at Stifel |
| May 7, 2026 11:47 am | — | UBS | $45.00 | $42.30 | TheFly | Bruker price target raised to $45 from $40 at UBS |
| May 7, 2026 9:28 am | Luke Sergott | Barclays | $53.00 | $42.30 | TheFly | Bruker price target raised to $53 from $45 at Barclays |
| February 13, 2026 2:44 pm | Evie Koslosky | Goldman Sachs | $35.00 | $37.19 | TheFly | Bruker price target lowered to $35 from $40 at Goldman Sachs |
| February 13, 2026 2:33 pm | — | UBS | $49.00 | $36.99 | TheFly | Bruker price target raised to $49 from $43 at UBS |
| February 13, 2026 11:09 am | Luke Sergott | Barclays | $50.00 | $37.51 | TheFly | Bruker price target lowered to $50 from $55 at Barclays |
| February 12, 2026 7:24 pm | — | Jefferies | $50.00 | $37.51 | TheFly | Bruker price target lowered to $50 from $55 at Jefferies |
| January 26, 2026 2:35 pm | — | Guggenheim | $58.00 | $49.03 | TheFly | Bruker price target raised to $58 from $53 at Guggenheim |
Latest News for BRKR
BREMEN, Germany--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of the DISQVER® clinical metagenomics platform from Noscendo GmbH.DISQVER® enables metagenomic next-generation sequencing (mNGS) analysis of microbes directly from blood samples, further expanding Bruker's NGS-based infection detection capabilities. Without any need for prior cultivation, DISQVER…
BRKR's rally is fueled by BSI NANO growth, AI-driven metrology demand and gains in preclinical imaging despite tariff pressures.
In this week's edition of InnovationRx, we look at biotech M&A, the rise of India's Anthem Biosciences, and more. To get it in your inbox, subscribe here.
On June 15, 2026, Bruker Corp (BRKR) shares rose 4.4% to a current price of $56.63. The stock has shown remarkable performance within the past year, with a 48.7
Bruker Corporation (BRKR) Presents at Jefferies Global Healthcare Conference 2026 Transcript
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.